|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009452,
umls-concept:C0026336,
umls-concept:C0036341,
umls-concept:C0040615,
umls-concept:C0085260,
umls-concept:C0212182,
umls-concept:C0231491,
umls-concept:C0289174,
umls-concept:C0439831,
umls-concept:C0441472,
umls-concept:C1522424
|
|
pubmed:issue |
4-5
|
|
pubmed:dateCreated |
1997-11-21
|
|
pubmed:abstractText |
The apparent antipsychotic action of the selective 5-HT2a receptor antagonist M100907 in MK-801-treated NMRI mice was shown to be markedly counteracted by the 5-HT2a/2c receptor antagonist ritanserin. The mechanism of action and potential implications are discussed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0300-9564
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
561-4
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9295186-Animals,
pubmed-meshheading:9295186-Antipsychotic Agents,
pubmed-meshheading:9295186-Dizocilpine Maleate,
pubmed-meshheading:9295186-Excitatory Amino Acid Antagonists,
pubmed-meshheading:9295186-Fluorobenzenes,
pubmed-meshheading:9295186-Male,
pubmed-meshheading:9295186-Mice,
pubmed-meshheading:9295186-Mice, Inbred Strains,
pubmed-meshheading:9295186-Motor Activity,
pubmed-meshheading:9295186-Piperidines,
pubmed-meshheading:9295186-Ritanserin,
pubmed-meshheading:9295186-Schizophrenia,
pubmed-meshheading:9295186-Serotonin Antagonists
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication).
|
|
pubmed:affiliation |
Department of Pharmacology, Göteborg University, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
